Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 565 | 305 | 934 | 63 | 1,189 |
| Gross Profit | 565 | 305 | 934 | 63 | 1,189 |
| Operating Expenses | 1,194 | 1,053 | 1,366 | 847 | 1,901 |
| Operating Income | -629 | -748 | -432 | -784 | -712 |
| Interest Expense | 0 | 285 | 0 | 0 | 0 |
| Other Income | 0 | 0 | -2 | 0 | 0 |
| Pre-tax Income | -629 | -1,033 | -434 | -784 | -712 |
| Net Income Continuous | -629 | -1,033 | -434 | -784 | -712 |
| Net Income | $-629 | $-1,033 | $-434 | $-784 | $-712 |
| EPS Basic Total Ops | -0.02 | -0.01 | 0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.02 | -0.01 | 0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-629 | $-475 | $-432 | $-784 | $-712 |